DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

DRG Epidemiology’s Global Lung Cancer Forecast, 2017-2027

This live session took place on Wednesday, December 6th, 2017.

Wei Wei Zhang presented DRG’s epidemiological forecast of all those living with lung cancer in 2017 and who will develop lung cancer by 2027. The numbers will be presented by world region and country income status, as well as by SCLC, NSCLC, and EGFR/ALK/KRAS mutations.

During this presentation, you will learn:

  • How many people worldwide are living with lung cancer in 2017, how will this number change over the coming decade, and what factors will be driving the change?
  • Which world regions have the greatest number of people living with lung cancer in 2017, and which region will show the greatest growth in cases over the coming decade?
  • Of all those people worldwide who are living with lung cancer in 2017, how many have SCLC or NSCLC or EGFR/ALK/KRAS mutations?

Presented by Wei Wei Zhang, Epidemiologist